The UK government aims to transform Britain into a “clean energy superpower” by 2030, with a target of 95% electricity generation from low-carbon sources. To achieve this, investments in renewables like wind and solar power, as well as storage and distribution infrastructure, are needed. However, the challenge lies in securing the £40 billion per year required for these investments, as the stock market funding for renewables has declined, leading to uncertainties in meeting the ambitious clean energy goals.
Full Article
3 Magnificent Stocks That Could Double or More by 2030
In a turbulent stock market, three Motley Fool contributors recommend investing in CRISPR Therapeutics, Summit Therapeutics, and Viking Therapeutics, which they believe could see significant gains by 2030. CRISPR Therapeutics, despite recent struggles, has a promising gene-editing therapy, Casgevy, and a robust pipeline. Summit Therapeutics is poised to challenge established drugs with its ivonescimab, while Viking Therapeutics offers potential through its GLP-1 drug, VK2735, with ongoing clinical trials targeting obesity and metabolic disorders. Full Article
Read more